This statistic shows the intravenous immunoglobulin (IVIG) global market share in 2015, by leading companies. Grifols held the largest market share with some ** percent while CSL and Baxalta held ** percent each.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Grifols. (June 7, 2017). Intravenous immunoglobulin (IVIG) global market share in 2015, by company [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 31, 2026, from /statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols. "Intravenous immunoglobulin (IVIG) global market share in 2015, by company." Chart. June 7, 2017. ÌÇÐÄÆÆ½â°æ. Accessed July 31, 2026. /statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols. (2017). Intravenous immunoglobulin (IVIG) global market share in 2015, by company. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 31, 2026. /statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols. "Intravenous Immunoglobulin (Ivig) Global Market Share in 2015, by Company." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 7 Jun 2017, /statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols, Intravenous immunoglobulin (IVIG) global market share in 2015, by company ÌÇÐÄÆÆ½â°æ, /statistics/758041/global-market-share-ivig-by-leading-companies/ (last visited July 31, 2026)
Intravenous immunoglobulin (IVIG) global market share in 2015, by company [Graph], Grifols, June 7, 2017. [Online]. Available: /statistics/758041/global-market-share-ivig-by-leading-companies/